Pancreatic Cancer Research

ResearcherChinese PLA General HospitalNo recent work listed

Fei Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5670-1944; OpenAlex author ID A5100455845. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers

Papers 4

  1. DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer. First author DOI 10.1186/s12885-023-11524-8↗
  2. 18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery. Co-author DOI 10.1186/s13550-023-00985-4↗
  3. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic… Co-author DOI 10.1080/21655979.2021.1992331↗
  4. Infiltrating CD4/CD8 high T cells shows good prognostic impact in pancreatic cancer. Last author PMID 31966748↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rong Liu · 3 shared papers, 2021–2023 · strength 0.53
  2. Lincheng Li · 2 shared papers, 2021–2023 · strength 0.35
  3. Zizheng Wang · 2 shared papers, 2021–2023 · strength 0.33
  4. Zhaoda Deng · 1 shared paper, 2023 · strength 0.20
  5. Zhiming Zhao · 1 shared paper, 2023 · strength 0.20
  6. Yue Zhang · 1 shared paper, 2023 · strength 0.18
  7. Gong Zhang · 1 shared paper, 2023 · strength 0.18
  8. Yanzhe Liu · 1 shared paper, 2023 · strength 0.18
  9. Minggen Hu · 1 shared paper, 2021 · strength 0.15
  10. Wenbo Zou · 1 shared paper, 2021 · strength 0.15
  11. Zhenxia Wang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.